Please login to the form below
Boehringer Ingelheim
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.
AbbVie shares positive results from head-to-head study of Skyrizi in Crohn's disease
Skyrizi, which is part of a collaboration between AbbVie and Boehringer Ingelheim, is already approved by the US Food and Drug Administration and the European Medicines Agency to treat Crohn’s
Boehringer and Lilly’s Jardiance granted MHRA approval to treat chronic kidney disease
Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as a treatment option for adults with chronic kidney disease (CKD).
Novartis sues US government over Medicare drug price negotiation programme
Other drugs selected for negotiation were Bristol Myers Squibb and Pfizer’s Eliquis (apixaban), Amgen's Enbrel (etanercept), AstraZeneca's Farxiga (dapagliflozin), Merck &Co's Januvia (sitagliptin), Eli Lilly and Boehringer ... The plan is facing court
US government announces first ten drugs subject to Medicare pricing negotiations
Boehringer Ingelheim's Jardiance (empagliflozin) and Novo Nordisk's Novolog/Fiasp (insulin aspart). ... However, the IRA’s price negotiation element is facing court challenges from leading drugmakers and industry groups, including Merck &Co, Bristol
AstraZeneca latest to sue US government over Medicare drug price negotiation plan
The plan already faces at least seven court challenges from leading drugmakers and industry groups, including Merck &Co, Bristol Myers Squibb, Johnson &Johnson, Boehringer Ingelheim and the Pharmaceutical Research and Manufacturers
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
CHASE
We are a leading provider of outsourced commercial, medical and recruitment services to UK pharmaceutical, biotech and healthcare companies....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
